Your browser doesn't support javascript.
loading
The genetic landscape of polycystic kidney disease in Ireland.
Benson, Katherine A; Murray, Susan L; Senum, Sarah R; Elhassan, Elhussein; Conlon, Eoin T; Kennedy, Claire; Conlon, Shane; Gilbert, Edmund; Connaughton, Dervla; O'Hara, Paul; Khamis, Sarah; Cormican, Sarah; Brody, Lawrence C; Molloy, Anne M; Lynch, Sally Ann; Casserly, Liam; Griffin, Matthew D; Carton, Robert; Yachnin, Kevin; Harris, Peter C; Cavalleri, Gianpiero L; Conlon, Peter.
Afiliação
  • Benson KA; School of Pharmacy and Biomolecular Science, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Murray SL; Department of Nephrology, Beaumont Hospital, Dublin, Ireland.
  • Senum SR; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
  • Elhassan E; Department of Nephrology, Beaumont Hospital, Dublin, Ireland.
  • Conlon ET; Department of Nephrology, Beaumont Hospital, Dublin, Ireland.
  • Kennedy C; Department of Nephrology, Beaumont Hospital, Dublin, Ireland.
  • Conlon S; Department of Nephrology, Beaumont Hospital, Dublin, Ireland.
  • Gilbert E; School of Pharmacy and Biomolecular Science, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Connaughton D; Department of Nephrology, Beaumont Hospital, Dublin, Ireland.
  • O'Hara P; Department of Renal Medicine, University Hospital Limerick, Limerick, Ireland.
  • Khamis S; School of Pharmacy and Biomolecular Science, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Cormican S; Regenerative Medicine Institute (REMEDI) at CÚRAM Centre for Research in Medical Devices, School of Medicine, National University of Ireland Galway, Galway, Ireland.
  • Brody LC; Nephrology Department, Galway University Hospitals, Saolta University Healthcare Group, Galway, Ireland.
  • Molloy AM; Division of Intramural Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
  • Lynch SA; School of Medicine, Trinity College Dublin, Dublin, Ireland.
  • Casserly L; Department of Clinical Genetics, Children's University Hospital, Temple Street, Dublin, Ireland.
  • Griffin MD; Department of Renal Medicine, University Hospital Limerick, Limerick, Ireland.
  • Carton R; Regenerative Medicine Institute (REMEDI) at CÚRAM Centre for Research in Medical Devices, School of Medicine, National University of Ireland Galway, Galway, Ireland.
  • Yachnin K; Nephrology Department, Galway University Hospitals, Saolta University Healthcare Group, Galway, Ireland.
  • Harris PC; School of Pharmacy and Biomolecular Science, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Cavalleri GL; Region Norrbotten, Kiruna Hospital, Kiruna, Sweden.
  • Conlon P; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Eur J Hum Genet ; 29(5): 827-838, 2021 05.
Article em En | MEDLINE | ID: mdl-33454723
ABSTRACT
Polycystic kidney diseases (PKDs) comprise the most common Mendelian forms of renal disease. It is characterised by the development of fluid-filled renal cysts, causing progressive loss of kidney function, culminating in the need for renal replacement therapy or kidney transplant. Ireland represents a valuable region for the genetic study of PKD, as family sizes are traditionally large and the population relatively homogenous. Studying a cohort of 169 patients, we describe the genetic landscape of PKD in Ireland for the first time, compare the clinical features of patients with and without a molecular diagnosis and correlate disease severity with autosomal dominant pathogenic variant type. Using a combination of molecular genetic tools, including targeted next-generation sequencing, we report diagnostic rates of 71-83% in Irish PKD patients, depending on which variant classification guidelines are used (ACMG or Mayo clinic respectively). We have catalogued a spectrum of Irish autosomal dominant PKD pathogenic variants including 36 novel variants. We illustrate how apparently unrelated individuals carrying the same autosomal dominant pathogenic variant are highly likely to have inherited that variant from a common ancestor. We highlight issues surrounding the implementation of the ACMG guidelines for variant pathogenicity interpretation in PKD, which have important implications for clinical genetics.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Renais Policísticas / Mutação Tipo de estudo: Guideline Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Hum Genet Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Renais Policísticas / Mutação Tipo de estudo: Guideline Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Hum Genet Ano de publicação: 2021 Tipo de documento: Article